<DOC>
	<DOCNO>NCT01614782</DOCNO>
	<brief_summary>The purpose study assess multiple rise dose safety/tolerability pharmacokinetics MK-5823 overweight/obese participant healthy overweight/obese participant Type 2 diabetes mellitus ( T2DM ) .</brief_summary>
	<brief_title>A Study Safety , Tolerability , Pharmacokinetics , Pharmacodynamics MK-5823 Overweight Obese Participants Who Are Healthy Have Type 2 Diabetes Mellitus ( MK-5823-002 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<criteria>Male female nonchildbearing potential A Body Mass Index 27 35 kg/m^2 weigh least 50 kg Judged good health T2DM Panels , good health diagnosis T2DM For T2DM Panels : diagnosis T2DM treat lifestyle management ( e.g . diet exercise ) alone combination stable dose metformin A nonsmoker and/or use nicotine nicotinecontaining product least approximately 6 month History stroke , chronic seizure major neurological disorder History clinically significant gastrointestinal , cardiovascular , hematological , hepatic , immunological , renal , respiratory , genitourinary abnormality disease . History clinically significant endocrine abnormality disease ( include type I type II , steroidinduced diabetes healthy participant panel ; exclude T2DM T2DM Panels ) Irritable bowel syndrome , recurrent nausea , vomit , diarrhea , abdominal pain . History neoplastic disease History cataract , diabetic retinopathy , macular edema , macular degeneration , vitreous hemorrhage , glaucoma , ocular surgery , ocular trauma blindness Requires treatment systemic ocular corticosteroid For T2DM Panels , history hypoglycemic unawareness For T2DM Panels , active treatment antihyperglycemic drug metformin For T2DM Panels , treatment peroxisome proliferatoractivated receptorgamma agonist ( e.g . Avandia Actos ) within 12 week study participation Unable refrain use medication begin 2 week study participation Consumes excessive amount alcohol ( &gt; 3 per day ) Consumes 6 caffeinated beverage per day Had major surgery donate lose 1 unit blood Participated another investigational study within 4 week study participation History significant multiple and/or severe allergy anaphylactic reaction Hypersensitivity glucagon insulin Uses illicit drug history drug alcohol abuse within 3 month study participation Woman childbearing potential nursing mother For T2DM Panels , age &gt; 50 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>